Browsing: drug
Alexandros MichailidisPfizer (NYSE:PFE) has decided to end R&D and marketing activities related to Beqvez, a one-time gene therapy the company…
kyolshinShares of Arcus Biosciences (NYSE:RCUS) hit a new 52-week low on Tuesday after the biotech said that Gilead Sciences’ (NASDAQ:GILD)…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a…
JHVEPhotoThe Trump administration fired workers at the Food and Drug Administration on Saturday night, health sciences publication STAT reported on…
Kameleon007/iStock via Getty ImagesShares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a…
PixelimagePresident Trump is likely to embrace the Medicare drug price negotiations that was initiated under the Biden administration, though the…
High risk warning: Foreign exchange trading carries a high level of risk that may not be suitable for all investors.…
travellinglight/iStock via Getty ImagesBiogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer’s drug,…
Jan. 29, 2025 2:30 PM ETPfizer Inc. (PFE) StockCMS, AMGN, GSK, BMY, MRK, TEVA, AZN, BHC, ALPMF, IRWD, ABBVBy: Val…
Md Saiful Islam KhanPfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as part of a combination regimen, reduced…